- <25$7.2M
1
- 27$29.2M
2
- 29$9.6M
3
- 103$9.2M
4
- 34$11.7M
5
- <25<$5M
6
Arcus Foundation
Non-Profit & Charitable Organizations · New York, United States · 41 Employees
The Arcus Foundation is an international charitable foundation focused on issues related to LGBT rights, social justice, ape conservation, and environmental preservation. The foundation was founded by Jon Stryker, heir to the Stryker Corporation medical supply company fortune. Stryker has explained the relationship between the foundations focus areas as bound by the common themes of compassion and justiceWe dont use the language of animal rights- its more about compassion and conservation languageAnother connection is justice. In our work for human rights, we are among those trying to expand traditional ideas of social justice to include sexuality and gendersocial justice for people can enable conservation." According to the OECD, Arcus Foundations financing for 2019 development decreased by 7% to US$15.1 million.Read More
View Company Info for Free
Who is Arcus Foundation
Headquarters
Phone Number
Website
Revenue
Industry
Top Competitors of Arcus Foundation
Arcus Foundation Org Chart
Arcus Foundation Tech Stack
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Arcus Foundation News & Media
Arcus Biosciences to Participate at Upcoming Virtual Investor Events
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate at the following upcoming February 2023 virtual investor events: SVB Securities Virtual Global Biopharma Conference Date: Tuesday, February 14th, 2023 Time: 12:00 p.m. ET Format: Fireside Chat Citi’s 2023 Virtual Oncology Leadership SArcus Biosciences Announces New Employment Inducement Grants
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensation Committee of the Company’s Board of Directors granted ten new employees options to purchase a total of 44,300 shares of the Company’s common stock at an exercise price per share of $22.02, which was the closing price on January 23, 2023, and restricted stock units to acquire a total of 22,150Arcus Biosciences Announces New Employment Inducement Grants
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensation Committee of the Company’s Board of Directors granted one new employee options to purchase a total of 1,450 shares of the Company’s common stock at an exercise price per share of $17.51, which was the closing price on January 9, 2023, and restricted stock units to acquire a total of 725 sharesArcus Biosciences Announces New Employment Inducement Grants - Business Wire
Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced t
Frequently Asked Questions regarding Arcus Foundation
The Arcus Foundation is an international charitable foundation focused on issues related to LGBT rights, social justice, ape conservation, and environmental preservation. The foundation was founded by Jon Stryker, heir to the Stryker Corporation medical supply company fortune. Stryker has explained the relationship between the foundations focus are... Read More